New tool aims to empower pregnant women in HIV prevention choices

NCT ID NCT06394323

Completed Prevention Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a counseling tool called MyChoice to help pregnant women in Malawi decide whether to use oral PrEP or condoms for HIV prevention. 100 HIV-negative pregnant women were randomly assigned to receive either the MyChoice shared decision-making intervention or standard counseling. The study measured how acceptable, appropriate, and feasible the intervention was, as well as its impact on decision-making confidence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: My Choice for HIV Prevention (MyChoice) – a counselor-delivered shared decision-making approach
What this could lead to: If successful, this approach could help pregnant women make more informed choices about HIV prevention, potentially increasing PrEP uptake and reducing HIV transmission.
What could go wrong: This is a small pilot study focused on feasibility, not effectiveness. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION

Contacts and locations

Locations

Bwaila Hospital

Lilongwe, Central Region, Malawi

More trials for these conditions

Other studies related to the condition(s) this trial covers.